The prognostic value of platelet endothelial cell adhesion molecule-1 in non-small-cell lung cancer patients

Kuang, Bo-hua; Wen, Xi-zhi; Ding, Ya; Peng, Rui-qing; Cai, Pei-qiang; Zhang, Meng-qing; Jiang, Feng; Zhang, Xiao-shi; Zhang, Xing
June 2013
Medical Oncology;Jun2013, Vol. 30 Issue 2, p1
Academic Journal
No abstract available.


Related Articles

  • Reduced survival in patients with early-stage non-small-cell lung cancer is associated with high pleural endothelial progenitor cell levels. Pirro, Matteo; Cagini, Lucio; Mannarino, Massimo R.; Andolfi, Marco; Potenza, Rossella; Paciullo, Francesco; Bianconi, Vanessa; Frangione, Maria Rosaria; Bagaglia, Francesco; Puma, Francesco; Mannarino, Elmo // European Journal of Cardio-Thoracic Surgery;Dec2016, Vol. 50 Issue 6, p1053 

    OBJECTIVES: Endothelial progenitor cells are capable of contributing to neovascularization in tumours. In patients with either malignant or transudative pleural effusion, we tested the presence of pleural endothelial progenitor cells. We also measured the number of endothelial progenitor cells...

  • Prognosis and Diagnosis.  // Current Medical Literature: Lung Cancer;2010, Vol. 4 Issue 2, p59 

    The article review studies related to the prognosis and diagnosis of non-small-cell lung cancer (NSCLC). It asserts the need to investigate further the prognostic role of standard uptake value (SUV) of primary NSCLC. On the association of cruciferous vegetable intake with reduced risk of lung...

  • Endocan as a Biomarker of Endothelial Dysfunction in Cancer. Stéphane, Sarrazin; Claude-Alain, Maurage; Dominique, Delmas; Philippe, Lassalle; Maryse, Delehedde // Journal of Cancer Science & Therapy;Mar2010, Vol. 2 Issue 2, p47 

    Endocan also called endothelial cell-specific-molecule-1 is a product of endothelial cells, highly regulated by vascular endothelial growth factor and expressed during the switch between dormant to fast-growing angiogenic tumors. No other molecule is currently known to be a read out of...

  • Prognostic significance of CD44s expression in resected non-small cell lung cancer.  // BMC Cancer;2011, Vol. 11 Issue 1, p340 

    The article focuses on a study which tries to determine the role of cell adhesion molecule CD44s in clinical outcomes of patients with resected non-small cell lung cancer (NSCLC). CD44 mediates cellular adhesion to the extracellular matrix, which helps in tumor cell migration. It included 159...

  • PET/CT in the Staging of the Non-Small-Cell Lung Cancer. Fangfang Chao; Hong Zhang // Journal of Biomedicine & Biotechnology;2012, Vol. 2012, p1 

    Lung cancer is a common disease and the leading cause of cancer-related death in many countries. Precise staging of patients with non-small-cell lung cancer plays an important role in determining treatment strategy and prognosis. Positron emission tomography/computed tomography (PET/CT),...

  • Chemotherapy plus Surgery versus Surgery Alone in Non-Small-Cell Lung Cancer. Rosell, Rafael // New England Journal of Medicine;6/16/94, Vol. 330 Issue 24, p1756 

    A letter to the editor is presented regarding the treatment of patients with non-small-cell lung cancer with chemotherapy and surgery.

  • Humeral Metastasis in Patients with Stage IV Non-Small–Cell Lung Cancer Portends a Short Life Expectancy. Ampil, Federico; Baluna, Roxana // Journal of Palliative Medicine;Oct2009, Vol. 12 Issue 10, p869 

    A letter to the editor is presented regarding the impact of humeral metastasis in patients with stage IV non-small-cell lung cancer.

  • Re: Akt Phosphorylation and Gefitinib Efficacy in Patients With Advanced Non-Small-Cell Lung Cancer. De Braud, Filippo; De Pas, Tommaso; Spaggiari, Lorenzo; Veronesi, Guilia; Curigliano, Giuseppe; Noberasco, Cristina; Pelosi, Giuseppe // JNCI: Journal of the National Cancer Institute;3/16/2005, Vol. 97 Issue 6, p461 

    Presents a letter to the editor concerning Akt phosphor and gefitinib efficacy in patients with advanced non-small-cell lung cancer.

  • Use of histological and genetic markers in optimizing therapy for patients with non-small-cell lung cancer.  // American Journal of Health-System Pharmacy;1/1/2010, Vol. 67 Issue 1, pS15 

    A quiz concerning the use of histological and genetic markers in the therapy optimization of non-small-cell lung cancer patients.

  • [F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients. Nappi, Antonio; Gallicchio, Rosj; Simeon, Vittorio; Nardelli, Anna; Pelagalli, Alessandra; Zupa, Angela; Vita, Giulia; Venetucci, Angela; Di Cosola, Michele; Barbato, Francesco; Storto, Giovanni // Radiology & Oncology;Dec2015, Vol. 49 Issue 4, p320 

    The article focuses on a study which aimed to evaluate the prognostic significance of standardized uptake value (SUVmax), metabolic tumour volume (MTV), and total lesion glycolysis (TLG) in patients with inoperable non-small-cell lung cancer (NSCLC). The study found that significant shorter PFS...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics